Syngene International Q3 Results
- BSE: 539268
- NSE: SYNGENE
- ISIN: INE398R01022
- Sector: Biotechnology & Drugs
BSE
455.00
10.60 (2.39%)
10.60 (2.39%)Volume88.31 K
Updated: Wed 10 Jun, 2026 | 15:29:58
NSE
454.6510.35 (2.33%)
10.35 (2.33%)Volume1.53 M
Updated: Wed 10 Jun, 2026 | 15:51:37
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q3 Results Highlights
Quarter ended Dec 25
Note: Comparison is on QoQ basis
Quarterly - Syngene International Q3 Results
*All figures in crores except per share values
| Fiscal Period | Dec 25 | Sep 24 | QoQ Comp | Dec 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 869.00 | 761.40 | 6.52% | 770.50 | 12.78% |
| Depreciation/ Amortization | 113.70 | 110.90 | -2.40% | 108.70 | 4.60% |
| Operating Income | 48.10 | 129.60 | -49.26% | 173.20 | -72.23% |
| Net Income | 15.00 | 106.10 | -77.65% | 131.10 | -88.56% |
| Other Operating Expenses Total | 187.90 | 162.40 | 1.13% | 174.90 | 7.43% |
| Net Income Before Taxes | 28.40 | 137.30 | -66.67% | 180.80 | -84.29% |
| Total Revenue | 917.10 | 891.00 | 0.71% | 943.70 | -2.82% |
| Selling/ General/ Admin Expenses Total | 267.40 | 251.50 | -2.76% | 249.50 | 7.17% |
| Diluted Normalized EPS | 1.29 | 2.64 | -22.77% | 3.26 | -60.44% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.